Literature DB >> 8613004

Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat.

M Zhang1, G Song, G Y Minuk.   

Abstract

BACKGROUND & AIMS: Cirrhosis is a potentially lethal condition for which there is no proven effective therapy. The aim of this study was to compare the effects of hepatic stimulator substance, traditional Chinese herbal medicine, selenium plus vitamin E, and ciprofloxacin treatment on biochemical and histological features of fibrosis in rats with carbon tetrachloride (CCl4)/ethanol-induced cirrhosis.
METHODS: One hundred twenty adult Wistar rats were divided into six study groups (20 rats/group): healthy controls, CCl4/ethanol-injured rats left untreated, and CCl4/ethanol-injured rats treated for 4 weeks with either hepatic stimulator substance, traditional Chinese herbal medicine, a combination of selenium plus vitamin E, or ciprofloxacin. After the 4-week treatment, rats were killed and the following parameters of hepatic fibrosis were determined: hepatic hydroxyproline and proline levels, serum hyaluronic acid concentrations, and histological staining of hepatic tissue.
RESULTS: Hepatic fibrosis was significantly improved in all four treated groups compared with the untreated CCl4/ethanol-injured controls. Improvements were most striking in the groups treated with traditional Chinese herbal medicine and ciprofloxacin.
CONCLUSIONS: The data indicate that hepatic stimulator substance, traditional Chinese herbal medicine, selenium plus vitamin E, and ciprofloxacin significantly decrease the amount of hepatic fibrosis caused by CCl4/ethanol injury in rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613004     DOI: 10.1053/gast.1996.v110.pm8613004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.

Authors:  Xuerui Yi; Ming Song; Youcheng Yuan; Xinrui Zhang; Wenyin Chen; Jin Li; Minghua Tong; Guangze Liu; Song You; Xiangping Kong
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

2.  Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.

Authors:  Ying Jiang; Miaoyun Zhao; Wei An
Journal:  J Mol Med (Berl)       Date:  2011-08-04       Impact factor: 4.599

3.  Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.

Authors:  Shi-Ling Song; Zuo-Jiong Gong; Quan-Rong Zhang; Tuan-Xin Huang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 5.  Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either.

Authors:  Phillipp Hartmann; Huikuan Chu; Yi Duan; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

6.  Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations.

Authors:  G Y Minuk; K Hawkins; K D E Kaita; S Wong; E Renner; L Minuk; J Uhanova
Journal:  Dig Dis Sci       Date:  2010-11-06       Impact factor: 3.199

Review 7.  Insights on augmenter of liver regeneration cloning and function.

Authors:  Elisavet Gatzidou; Gregory Kouraklis; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

8.  Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.

Authors:  C Guarner; B A Runyon; M Heck; S Young; M Y Sheikh
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

9.  Protective effect of selenium-enriched Lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms.

Authors:  Long Chen; Dao-Dong Pan; Juan Zhou; Ying-Zi Jiang
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

10.  Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure.

Authors:  H Kojima; K D E Kaita; K Hawkins; J Uhanova; G Y Minuk
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.